Published by Josh White on 29th April 2025
(Sharecast News) - AstraZeneca delivered a strong performance in the first quarter of 2025, it announced on Tuesday, with total revenue rising 10% at constant exchange rates to $13.59bn, supported by double-digit growth in oncology and biopharmaceuticals across all major regions.
URL: http://www.digitallook.com/dl/news/story/35042464/...